Annual Accounts Payable
$1.07 M
-$553.00 K-34.14%
December 31, 2023
Summary
- As of February 7, 2025, ERNA annual accounts payable is $1.07 million, with the most recent change of -$553.00 thousand (-34.14%) on December 31, 2023.
- During the last 3 years, ERNA annual accounts payable has fallen by -$208.00 thousand (-16.31%).
- ERNA annual accounts payable is now -39.20% below its all-time high of $1.75 million, reached on December 31, 2021.
Performance
ERNA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.19 M
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, ERNA quarterly accounts payable is $2.19 million, unchanged on September 30, 2024.
- Over the past year, ERNA quarterly accounts payable has increased by +$1.13 million (+105.53%).
- ERNA quarterly accounts payable is now -40.40% below its all-time high of $3.68 million, reached on June 1, 2021.
Performance
ERNA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ERNA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.1% | +105.5% |
| 3 y3 years | -16.3% | +50.1% |
| 5 y5 years | -16.3% | +50.1% |
ERNA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.2% | at low | -18.0% | +105.5% |
| 5 y | 5-year | -39.2% | at low | -40.4% | +120.1% |
| alltime | all time | -39.2% | at low | -40.4% | +120.1% |
Eterna Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.19 M(0.0%) |
| Jun 2024 | - | $2.19 M(+6.3%) |
| Mar 2024 | - | $2.06 M(+93.3%) |
| Dec 2023 | $1.07 M(-34.1%) | $1.07 M(-27.1%) |
| Sep 2023 | - | $1.46 M(-45.3%) |
| Jun 2023 | - | $2.67 M(+83.1%) |
| Mar 2023 | - | $1.46 M(-9.8%) |
| Dec 2022 | $1.62 M | $1.62 M(+40.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.15 M(-22.2%) |
| Jun 2022 | - | $1.48 M(+33.6%) |
| Mar 2022 | - | $1.11 M(-37.0%) |
| Dec 2021 | $1.75 M(+37.6%) | - |
| Dec 2021 | - | $1.75 M(+76.2%) |
| Sep 2021 | - | $996.30 K(-72.9%) |
| Jun 2021 | - | $3.68 M(+103.1%) |
| Mar 2021 | - | $1.81 M(+42.1%) |
| Dec 2020 | $1.27 M | $1.27 M |
FAQ
- What is Eterna Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Eterna Therapeutics?
- What is Eterna Therapeutics annual accounts payable year-on-year change?
- What is Eterna Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly accounts payable year-on-year change?
What is Eterna Therapeutics annual accounts payable?
The current annual accounts payable of ERNA is $1.07 M
What is the all time high annual accounts payable for Eterna Therapeutics?
Eterna Therapeutics all-time high annual accounts payable is $1.75 M
What is Eterna Therapeutics annual accounts payable year-on-year change?
Over the past year, ERNA annual accounts payable has changed by -$553.00 K (-34.14%)
What is Eterna Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ERNA is $2.19 M
What is the all time high quarterly accounts payable for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly accounts payable is $3.68 M
What is Eterna Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ERNA quarterly accounts payable has changed by +$1.13 M (+105.53%)